Cargando…

Cardiovascular risk management in patients with severe mental illness or taking antipsychotics: A qualitative study on barriers and facilitators among dutch general practitioners

BACKGROUND: Patients with severe mental illness (SMI) or receiving treatment with antipsychotics (APs) have an increased risk of cardiovascular disease. Cardiovascular risk management (CVRM) increasingly depends on general practitioners (GPs) because of the shift of mental healthcare from secondary...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakobs, Kirsti, Lautan, Latoya, Lucassen, Peter, Janzing, Joost, van Lieshout, Jan, Biermans, Marion C. J., Bischoff, Erik W. M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272927/
https://www.ncbi.nlm.nih.gov/pubmed/35796600
http://dx.doi.org/10.1080/13814788.2022.2092093
_version_ 1784744972976652288
author Jakobs, Kirsti
Lautan, Latoya
Lucassen, Peter
Janzing, Joost
van Lieshout, Jan
Biermans, Marion C. J.
Bischoff, Erik W. M. A.
author_facet Jakobs, Kirsti
Lautan, Latoya
Lucassen, Peter
Janzing, Joost
van Lieshout, Jan
Biermans, Marion C. J.
Bischoff, Erik W. M. A.
author_sort Jakobs, Kirsti
collection PubMed
description BACKGROUND: Patients with severe mental illness (SMI) or receiving treatment with antipsychotics (APs) have an increased risk of cardiovascular disease. Cardiovascular risk management (CVRM) increasingly depends on general practitioners (GPs) because of the shift of mental healthcare from secondary to primary care and the surge of off-label AP prescriptions. Nevertheless, the uptake of patients with SMI/APs in CVRM programmes in Dutch primary care is low. OBJECTIVES: To explore which barriers and facilitators GPs foresee when including and treating patients with SMI or using APs in an existing CVRM programme. METHODS: In 2019, we conducted a qualitative study among 13 Dutch GPs. During individual in-depth, semi-structured interviews a computer-generated list of eligible patients who lacked annual cardiovascular risk (CVR) screening guided the interview. Data was analysed thematically. RESULTS: The main barriers identified were: (i) underestimation of patient CVR and ambivalence to apply risk-lowering strategies such as smoking cessation, (ii) disproportionate burden on GPs in deprived areas, (iii) poor information exchange between GPs and psychiatrists, and (iv) scepticism about patient compliance, especially those with more complex conditions. The main facilitators included: (i) support of GPs through a computer-generated list of eligible patients and (ii) involvement of family or carers. CONCLUSION: This study displays a range of barriers and facilitators anticipated by GPs. These indicate the preconditions required to remove barriers and facilitate GPs, namely adequate recommendations in practice guidelines, improved consultation opportunities with psychiatrists, practical advice to support patient adherence and incentives for practices in deprived areas.
format Online
Article
Text
id pubmed-9272927
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-92729272022-07-12 Cardiovascular risk management in patients with severe mental illness or taking antipsychotics: A qualitative study on barriers and facilitators among dutch general practitioners Jakobs, Kirsti Lautan, Latoya Lucassen, Peter Janzing, Joost van Lieshout, Jan Biermans, Marion C. J. Bischoff, Erik W. M. A. Eur J Gen Pract Original Articles BACKGROUND: Patients with severe mental illness (SMI) or receiving treatment with antipsychotics (APs) have an increased risk of cardiovascular disease. Cardiovascular risk management (CVRM) increasingly depends on general practitioners (GPs) because of the shift of mental healthcare from secondary to primary care and the surge of off-label AP prescriptions. Nevertheless, the uptake of patients with SMI/APs in CVRM programmes in Dutch primary care is low. OBJECTIVES: To explore which barriers and facilitators GPs foresee when including and treating patients with SMI or using APs in an existing CVRM programme. METHODS: In 2019, we conducted a qualitative study among 13 Dutch GPs. During individual in-depth, semi-structured interviews a computer-generated list of eligible patients who lacked annual cardiovascular risk (CVR) screening guided the interview. Data was analysed thematically. RESULTS: The main barriers identified were: (i) underestimation of patient CVR and ambivalence to apply risk-lowering strategies such as smoking cessation, (ii) disproportionate burden on GPs in deprived areas, (iii) poor information exchange between GPs and psychiatrists, and (iv) scepticism about patient compliance, especially those with more complex conditions. The main facilitators included: (i) support of GPs through a computer-generated list of eligible patients and (ii) involvement of family or carers. CONCLUSION: This study displays a range of barriers and facilitators anticipated by GPs. These indicate the preconditions required to remove barriers and facilitate GPs, namely adequate recommendations in practice guidelines, improved consultation opportunities with psychiatrists, practical advice to support patient adherence and incentives for practices in deprived areas. Taylor & Francis 2022-07-07 /pmc/articles/PMC9272927/ /pubmed/35796600 http://dx.doi.org/10.1080/13814788.2022.2092093 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Jakobs, Kirsti
Lautan, Latoya
Lucassen, Peter
Janzing, Joost
van Lieshout, Jan
Biermans, Marion C. J.
Bischoff, Erik W. M. A.
Cardiovascular risk management in patients with severe mental illness or taking antipsychotics: A qualitative study on barriers and facilitators among dutch general practitioners
title Cardiovascular risk management in patients with severe mental illness or taking antipsychotics: A qualitative study on barriers and facilitators among dutch general practitioners
title_full Cardiovascular risk management in patients with severe mental illness or taking antipsychotics: A qualitative study on barriers and facilitators among dutch general practitioners
title_fullStr Cardiovascular risk management in patients with severe mental illness or taking antipsychotics: A qualitative study on barriers and facilitators among dutch general practitioners
title_full_unstemmed Cardiovascular risk management in patients with severe mental illness or taking antipsychotics: A qualitative study on barriers and facilitators among dutch general practitioners
title_short Cardiovascular risk management in patients with severe mental illness or taking antipsychotics: A qualitative study on barriers and facilitators among dutch general practitioners
title_sort cardiovascular risk management in patients with severe mental illness or taking antipsychotics: a qualitative study on barriers and facilitators among dutch general practitioners
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272927/
https://www.ncbi.nlm.nih.gov/pubmed/35796600
http://dx.doi.org/10.1080/13814788.2022.2092093
work_keys_str_mv AT jakobskirsti cardiovascularriskmanagementinpatientswithseverementalillnessortakingantipsychoticsaqualitativestudyonbarriersandfacilitatorsamongdutchgeneralpractitioners
AT lautanlatoya cardiovascularriskmanagementinpatientswithseverementalillnessortakingantipsychoticsaqualitativestudyonbarriersandfacilitatorsamongdutchgeneralpractitioners
AT lucassenpeter cardiovascularriskmanagementinpatientswithseverementalillnessortakingantipsychoticsaqualitativestudyonbarriersandfacilitatorsamongdutchgeneralpractitioners
AT janzingjoost cardiovascularriskmanagementinpatientswithseverementalillnessortakingantipsychoticsaqualitativestudyonbarriersandfacilitatorsamongdutchgeneralpractitioners
AT vanlieshoutjan cardiovascularriskmanagementinpatientswithseverementalillnessortakingantipsychoticsaqualitativestudyonbarriersandfacilitatorsamongdutchgeneralpractitioners
AT biermansmarioncj cardiovascularriskmanagementinpatientswithseverementalillnessortakingantipsychoticsaqualitativestudyonbarriersandfacilitatorsamongdutchgeneralpractitioners
AT bischofferikwma cardiovascularriskmanagementinpatientswithseverementalillnessortakingantipsychoticsaqualitativestudyonbarriersandfacilitatorsamongdutchgeneralpractitioners